---
title: 'Manufacturing Daily Summary: What Happened on November 10, 2026'
headline: Small molecules stay central to drug outsourcing
description: CPHI executives said traditional chemistry remains a core part of the
  industry.
url: https://thebench.bio/news/manufacturing/2026-11-10
topic: manufacturing
date: '2026-11-10'
covers:
- '2026-11-10'
date_published: '2026-11-10T12:04:09Z'
date_modified: '2026-11-10T12:04:09Z'
tags:
- Industry
sources: 1
publisher: TheBench.Bio
---

# Manufacturing Daily Summary: What Happened on November 10, 2026

**Small molecules stay central to drug outsourcing**

CPHI executives said traditional chemistry remains a core part of the industry.

## Today in brief

Drug outsourcing firms have not abandoned small molecules, executives at CPHI said. [1]

## Also worth knowing

- Executives at CPHI said traditional chemistry continues to anchor drug outsourcing. [1]

## Sources

1. [No, drug outsourcing firms haven’t abandoned the small molecule](<https://cen.acs.org/business/outsourcing/drug-outsourcing-firms-havent-abandoned/104/web/2026/11?sc=230901_cenrssfeed_eng_Pharmaceuticalsrss_cen>), C&EN Pharmaceuticals, 2026-11-10

---

TheBench.Bio wrote this from the reporting cited above, with a language model drafting and editing.

[1]: <https://cen.acs.org/business/outsourcing/drug-outsourcing-firms-havent-abandoned/104/web/2026/11?sc=230901_cenrssfeed_eng_Pharmaceuticalsrss_cen>